InreLoestrin24FeAntitrustLitigation.com
Insurance · Wisconsin, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
PO Box 173085, Milwaukee, Wisconsin, 532...Phone Number
(877) 324-0380Revenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About InreLoestrin24FeAntitrustLitigation.com
Lupin Limited and Lupin Pharmaceuticals, Inc. are involved in a class action settlement related to the oral contraceptives Loestrin 24 Fe and Minastrin 24 Fe. They have agreed to a settlement to resolve claims of antitrust violations and unlawful delays in the availability of generic versions of these medications. The intended clients for the settlement include third-party payors (TPPs) such as health insurers and employer-provided health care plans. The settlements aim to reimburse TPPs for costs incurred in purchasing these contraceptives.Explore more
InreLoestrin24FeAntitrustLitigation.com Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is InreLoestrin24FeAntitrustLitigation.com your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at InreLoestrin24FeAntitrustLitigation.com
Check if InreLoestrin24FeAntitrustLitigation.com has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
InreLoestrin24FeAntitrustLitigation.com, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once InreLoestrin24FeAntitrustLitigation.com has new funding data
Earning: See what the market has to say on InreLoestrin24FeAntitrustLitigation.com recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when InreLoestrin24FeAntitrustLitigation.com launches new products
Check out if InreLoestrin24FeAntitrustLitigation.com is spiking on competitors!
Click to see if InreLoestrin24FeAntitrustLitigation.com had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined InreLoestrin24FeAntitrustLitigation.com as Masked Content
Find more new buyers
Compare Similar Companies to InreLoestrin24FeAntitrustLitigation.com
Compare insights from companies similar to InreLoestrin24FeAntitrustLitigation.com, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
InreLoestrin24FeAntitrustLitigation.com is experiencing very low activity levels compared to other companies in the Insurance sector.
What does this means?
InreLoestrin24FeAntitrustLitigation.com is drawing exceptional interest within the Insurance industry, suggesting notable developments or strong market momentum, learn more about InreLoestrin24FeAntitrustLitigation.com.
InreLoestrin24FeAntitrustLitigation.com Tech Stack
A closer look at the technologies used by InreLoestrin24FeAntitrustLitigation.com
Top Insurance Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding InreLoestrin24FeAntitrustLitigation.com
Sign Up For FreeTo access detailed company insights
Lupin Limited and Lupin Pharmaceuticals, Inc. are involved in a class action settlement related to the oral contraceptives Loestrin 24 Fe and Minastrin 24 Fe. They have agreed to a settlement to resolve claims of antitrust violations and unlawful delays in the availability of generic versions of these medications. The intended clients for the settl... Read More
